Drupal.behaviors.print = function(context) {window.print();window.close();}>
Marina Inks $1M Licensing Deal with Novartis for Oligo Technology
August 09, 2012
Marina Inks $1M Licensing Deal with Novartis for Oligo Technology
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Marina Releases Data on miRNA Antagonists, Inks Deal for Up to $15M Investment
October 20, 2011 / Gene Silencing News
Lundbeck, Debiopharm Join List of Pharmas Looking to RNAi
February 3, 2011 / Gene Silencing News
Calando, Others Miss 2010 Partnering Guidance as Industry Takes Sober View of RNAi
January 6, 2011 / Gene Silencing News
Silence Says It Is In Talks Over Potential Sale
September 9, 2010 / Gene Silencing News
As Big Pharma Looks to Niche Diseases, RNAi May Benefit
May 30, 2013 / Gene Silencing News